EW
JNJ icon

Evoke Wealth’s Johnson & Johnson JNJ Stock Holding History

Evoke Wealth’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.2M Sell
66,369
-12,394
-16% -$2.89M 0.29% 45
2025
Q4 		$16.3M Buy
78,763
+1,922
+3% +$380K 0.3% 44
2025
Q3 		$14.2M Buy
76,841
+1,845
+2% +$316K 0.29% 46
2025
Q2 		$11.5M Buy
74,996
+1,632
+2% +$251K 0.26% 49
2025
Q1 		$12.2M Sell
73,364
-5,477
-7% -$857K 0.32% 43
2024
Q4 		$11.4M Sell
78,841
-1,422
-2% -$220K 0.32% 42
2024
Q3 		$13M Buy
+80,263
New +$12.8M 0.35% 39
2024
Q2 		– Sell
-81,166
Closed -$12.8M – 249
2024
Q1 		$12.8M Buy
+81,166
New +$12.9M 0.38% 39
2023
Q4 		– Sell
-97,070
Closed -$15.1M – 223
2023
Q3 		$15.1M Sell
97,070
-1,172
-1% -$193K 0.53% 28
2023
Q2 		$16.3M Buy
98,242
+18,249
+23% +$2.95M 0.56% 29
2023
Q1 		$12.4M Sell
79,993
-1,348
-2% -$218K 0.45% 29
2022
Q4 		$14.4M Buy
81,341
+109
+0.1% +$18.8K 0.52% 32
2022
Q3 		$13.3M Sell
81,232
-163
-0.2% -$27.6K 0.54% 26
2022
Q2 		$14.4M Buy
81,395
+3,379
+4% +$602K 0.53% 27
2022
Q1 		$13.8M Sell
78,016
-552
-0.7% -$93.9K 0.45% 33
2021
Q4 		$13.4M Buy
78,568
+102
+0.1% +$16.7K 0.42% 33
2021
Q3 		$12.7M Sell
78,466
-63,025
-45% -$10.8M 0.48% 28
2021
Q2 		$23.3M Buy
141,491
+3,284
+2% +$544K 0.88% 20
2021
Q1 		$22.7M Buy
138,207
+121,125
+709% +$19.6M 1.03% 20
2020
Q4 		$2.69M Buy
17,082
+1,236
+8% +$182K 0.18% 38
2020
Q3 		$2.36M Sell
15,846
-59
-0.4% -$8.73K 0.19% 43
2020
Q2 		$2.24M Sell
15,905
-556
-3% -$81K 0.22% 34
2020
Q1 		$2.16M Sell
16,461
-2,939
-15% -$417K 0.31% 31
2019
Q4 		$2.83M Sell
19,400
-2,056
-10% -$279K 0.36% 29
2019
Q3 		$2.78M Buy
+21,456
New +$2.83M 0.34% 39

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Evoke Wealth's JNJ Position: Q1 2026 in Review

Evoke Wealth reduced its Johnson & Johnson (JNJ) stake by 16% in Q1 2026, selling an estimated $2.89M and leaving 66,369 shares worth $16.2M. The position accounts for 0.29% of the portfolio, ranked #45.

Evoke Wealth first reported a position in JNJ in Q3 2019 and has held it in 25 quarters since. The position peaked at $23.3M in Q2 2021. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Evoke Wealth held 66,369 shares of Johnson & Johnson worth $16.2M as of Q1 2026.
  • Evoke Wealth sold 12,394 Johnson & Johnson shares in Q1 2026, an estimated $2.89M.
  • Johnson & Johnson made up 0.29% of Evoke Wealth's portfolio in Q1 2026, its #45 holding.
  • Evoke Wealth first reported a position in Johnson & Johnson in Q3 2019 and has held it in 25 quarters since.
  • Evoke Wealth's Johnson & Johnson position peaked at $23.3M in Q2 2021.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Evoke Wealth's 13F filing for Q1 2026, filed 15 May 2026.